Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial (Q43951696)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial |
scientific article |
Statements
1 reference
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
S Loibl
1 reference
P-L Kellokumpu-Lehtinen
1 reference
R Salgado
1 reference
N Sirtaine
1 reference
D Fumagalli
1 reference
P Bono
1 reference
M J Piccart
1 reference
C Sotiriou
1 reference
7 March 2014
1 reference
1 reference